Immunotherapy and Immune Checkpoints

Antibody therapies are the most successful immunotherapy, treating a wide range of cancers. Antibodies are proteins produced by the immune system that bind to a target antigen on the cell surface. In normal physiology the immune system uses them to fight pathogens. Each antibody is specific to one or a few proteins. Those that bind to cancer antigens are used to treat cancer. Cell surface receptors are common targets for antibody therapies. Among the most promising approaches to activating therapeutic antitumor immunity is the blockade of immune checkpoints. Immune checkpoints refer to a plethora of inhibitory pathways hardwired into the immune system that are crucial for maintaining self-tolerance and modulating the duration and amplitude of physiological immune responses in peripheral tissues in order to minimize collateral tissue damage. It is now clear that tumors co-opt certain immune-checkpoint pathways as a major mechanism of immune resistance, particularly against T cells that are specific for tumor antigens. Because many of the immune checkpoints are initiated by ligand–receptor interactions, they can be readily blocked by antibodies or modulated by recombinant forms of ligands or receptors. Cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) antibodies were the first of this class of immunetherapeutics to achieve US Food and Drug Administration (FDA) approval.

Preliminary clinical findings with blockers of additional immune-checkpoint proteins, such as programmed cell death protein 1 (PD1), indicate broad and diverse opportunities to enhance antitumor immunity with the potential to produce durable clinical responses.

  • Combinations of Check-Point Inhibitors
  • In Vivo Discovery of Immunotherapy Targets
  • Immune Suppression and Microenvironment
  • Sequencing or Combination Approaches in Immunotherapy
  • Chimeric Antigen Receptor Re-Directed T Cell Therapy

Related Conference of Immunotherapy and Immune Checkpoints

April 19-20, 2018

7th World Congress on Immunology

Amsterdam, Netherlands
May 16-17, 2018

World Congress on Allergy and Immunotherapy

Osaka, Japan
July 12-13, 2018

5th International Conference on Parasitology

Paris, France
September 13-14, 2018

World Conference on Vaccine and Immunization

Romania
September 13-14, 2018

11th Annual Congress on Immunology & Immunotechnology

Zurich, Switzerland
September 17-18, 2018

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

San Diego, California, USA
September 17-18, 2018

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

San Diego, California, USA
September 20-21, 2018

Global Meet on Immunology and Molecular Biology

Oslo, Norway
October 19-20, 2018

10th World Congress and Expo on Immunology

New York, USA
October 29-30, 2018

6th International Conference on HIV/AIDS, STDs and STIs

San Francisco, USA
November 26-27, 2018

3rd International Conference on Autoimmunity

Dublin, Ireland
December 05-06, 2018

4th Antibodies, Antibiotics and Bio Therapeutics Congress

Chicago, Illinois, USA
December 05-06-2018

Conference on Biostatistics and Informatics

Dubai, UAE

Immunotherapy and Immune Checkpoints Conference Speakers

Recommended Sessions

Related Journals

Are you interested in